| CUSTOMER |
CUSTOMER |
92%
|
For each of the nine months ended March 31, 2026 and 2025, one customer accounted for 99.1 % and 96.5 % of revenue |
| ONE-CUSTOMER |
ONE-CUSTOMER |
90%
|
one customer accounted for 99.9 % of commission revenue |
| CONSULTING-CO-LTD |
CONSULTING-CO-LTD |
62%
|
h Consulting Co., Ltd. or Inner Mongolia Tianju Health Consulting Company Limited. Among the principal terms of the Sales Agency Agreements are: ● Honghai is responsible for developing and providing … |
| INNER-MONGOLIA-CHENGHENG-HEALTH-CONSULTING-CO-LT |
INNER-MONGOLIA-CHENGHENG-HEALTH-CONSULTING-CO-LT |
62%
|
on Ozone Therapy Device – Autologous Blood Immunotherapy - prevention and treatment of cardiovascular and cerebrovascular diseases relying on the use of an ozone therapy device to remove pathogens an… |
| INNER-MONGOLIA-CHENGHENG-HEALTH-CONSULTING-COMPA |
INNER-MONGOLIA-CHENGHENG-HEALTH-CONSULTING-COMPA |
62%
|
( 9,307 ) 83,766 Net increase in cash and cash equivalents 267,480 779,890 Cash and cash equivalents, beginning of year 1,136,562 356,672 Cash and cash equivalents, end of year $ 1,404,042 $ 1,136,56… |
| INNER-MONGOLIA-JIUZUN-HEALTH-EXAMINATION-CO-LTD |
INNER-MONGOLIA-JIUZUN-HEALTH-EXAMINATION-CO-LTD |
62%
|
on Ozone Therapy Device – Autologous Blood Immunotherapy - prevention and treatment of cardiovascular and cerebrovascular diseases relying on the use of an ozone therapy device to remove pathogens an… |
| INNER-MONGOLIA-QINGUO-HEALTH-CONSULTING-CO-LTD |
INNER-MONGOLIA-QINGUO-HEALTH-CONSULTING-CO-LTD |
62%
|
on Ozone Therapy Device – Autologous Blood Immunotherapy - prevention and treatment of cardiovascular and cerebrovascular diseases relying on the use of an ozone therapy device to remove pathogens an… |
| INNER-MONGOLIA-RONGBIN-HEALTH-CONSULTING-CO-LTD |
INNER-MONGOLIA-RONGBIN-HEALTH-CONSULTING-CO-LTD |
62%
|
lars of the Company will decline. ● We may become subject to a variety of laws and regulations in the PRC regarding privacy, data security, cybersecutiry, and data protection. We may be liable for im… |
| INNER-MONGOLIA-TIANJU-HEALTH-CONSULTING-COMPANY- |
INNER-MONGOLIA-TIANJU-HEALTH-CONSULTING-COMPANY- |
62%
|
( 9,307 ) 83,766 Net increase in cash and cash equivalents 267,480 779,890 Cash and cash equivalents, beginning of year 1,136,562 356,672 Cash and cash equivalents, end of year $ 1,404,042 $ 1,136,56… |
| TECHNOLOGY-CO-LTD |
TECHNOLOGY-CO-LTD |
62%
|
lth Technology Co., Ltd and Ulanqab Mengzhong Rehabilitation TCM Hospital Co., Ltd, which is located in Ulanqab. Under the terms of this agreement, Ulanqab Mengzhong Rehabilitation TCM Hospital Co., … |
| ULANQAB-MENGZHONG-REHABILITATION-TCM-HOSPITAL-CO |
ULANQAB-MENGZHONG-REHABILITATION-TCM-HOSPITAL-CO |
62%
|
lth Technology Co., Ltd and Ulanqab Mengzhong Rehabilitation TCM Hospital Co., Ltd, which is located in Ulanqab. Under the terms of this agreement, Ulanqab Mengzhong Rehabilitation TCM Hospital Co., … |
